Failure to Provide Ordered Medications and Monitoring
Summary
The facility failed to provide ordered diabetes care for a resident with diabetes, anxiety disorder, chronic kidney disease, and acute and chronic respiratory failure. The resident had physician orders for Lantus 10 units twice daily with instructions to hold for blood sugar less than 150, Humalog 15 units three times daily with the same hold parameter, and blood sugar checks twice daily. The MARs showed multiple instances where Lantus was given when the recorded blood sugar was below 150, and multiple Humalog administrations were documented without blood sugar readings recorded on the MAR. During interview, the CNC stated the insulin should have been held as ordered and was unsure why blood sugar results were not documented for the Humalog doses. The facility also failed to monitor and document the effectiveness of an as-needed anxiety medication for the same resident. A physician ordered hydroxyzine 25 mg every 8 hours as needed for anxiety, and an observation of the medication cart showed six pills missing from the card. The September MAR did not show that hydroxyzine had been administered since it was ordered. The ADON stated the doses should have been documented on the MAR when given and the effectiveness of the dose should have been documented. For another resident with dysphasia and left shoulder pain, the facility failed to ensure an ordered narcotic pain medication was administered as prescribed. The resident had an order for oxycodone-acetaminophen 5-325 mg via gastric tube every 6 hours as needed for pain, but an incident report showed she received Norco 5-325 mg instead of the ordered oxycodone 5-325 mg. The resident was stable and had no adverse side effects noted, and the CNC stated the resident should have received her pain medication as ordered. The facility also failed to timely address an antidepressant dosage that was not available from the pharmacy for another resident with kidney disease. The resident’s bupropion order was increased from 150 mg to 225 mg daily, but the August MAR showed multiple days when the 1.5-tablet dose was not given. Facility leadership stated the pharmacy did not notify them until several days later that the medication could not be supplied as half tablets, and the provider was not notified until after the delay. The order was later changed to 300 mg daily. In addition, the facility failed to administer ordered eye medication for a resident with an infected ocular socket lesion, conjunctival injury, corneal abrasion, and impaired visual function with only left-eye vision. The resident had an order for Refresh Celluvisc Ophthalmic Gel 1% in both eyes four times daily, and the MARs showed it as administered as ordered. However, a family member who was present in the facility all day on two days stated he did not see nursing staff administer the drops. An inspection of the medication cart found two boxes of the eye medication with remaining doses, and the pharmacist stated there had been a long lapse in refilling the medication.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.